IperionX Limited (IPX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    IperionX Limited

    NASDAQ: IPX · Real-Time Price · USD
    43.84
    0.15 (0.34%)
    At close: Sep 10, 2025, 3:59 PM
    44.68
    1.92%
    After-hours: Sep 10, 2025, 04:11 PM EDT

    IperionX Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 657.16K 634.11K 211.58K 9.38K
    Gross Profit
    		 -657.16K -634.11K -211.58K -9.38K
    Operating Income
    		 -23.01M -26.26M -21.85M -9.93M
    Interest Income
    		 555.59K 207.68K 24.04K 3.81K
    Pretax Income
    		 -22.23M -25.93M -21.52M -9.93M
    Net Income
    		 -22.23M -25.93M -21.52M -9.93M
    Selling & General & Admin
    		 13.49M 17.3M 11.4M 3.71M
    Research & Development
    		 8.87M 8.33M 3.21M 180.19K
    Other Expenses
    		 n/a 60.47K n/a -3.86M
    Operating Expenses
    		 22.36M 25.62M 21.87M 9.93M
    Interest Expense
    		 -90.38K 131.03K 45.54K 5.62K
    Selling & Marketing Expenses
    		 3.65M 10.72M n/a n/a
    Cost & Expenses
    		 23.01M 26.26M 21.87M 9.93M
    Income Tax Expense
    		 -382.42K -2 45.54K -9.38K
    Shares Outstanding (Basic)
    		 21.78M 16.8M 13.46M 13.2M
    Shares Outstanding (Diluted)
    		 21.78M 16.8M 13.46M 13.2M
    EPS (Basic)
    		 -1 -1.5 -1.6 -0.75
    EPS (Diluted)
    		 -1 -1.5 -1.6 -0.75
    EBITDA
    		 -22.49M -25.62M -29.39M -13.3M
    EBIT
    		 -22.62M -25.8M -29.6M -17.73M
    Depreciation & Amortization
    		 124.75K 634.11K 211.58K 9.38K

    Add to Watchlist